CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders

Title:CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders

Volume: 22

Author(s): Wei Guan, Mei-Xin Ni, Hai-Juan Gu and Yang Yang*

Affiliation:

• Department of Pharmacy, Affiliated Tumor Hospital of Nantong University/Nantong Tumor Hospital, Nantong, Jiangsu 226361, China

Keywords: CREB, depression, human diseases, expression levels, target gene, psychiatric disorders.

Abstract: Psychiatric disorders are complex, multifactorial illnesses. It is challenging for us to understand the underlying mechanism of psychiatric disorders. In recent years, the morbidity of psychiatric disorders has increased yearly, causing huge economic losses to the society. Although some progress, such as psychotherapy drugs and electroconvulsive therapy, has been made in the treatment of psychiatric disorders, including depression, anxiety, bipolar disorder, obsessive-compulsive and autism spectrum disorders, antidepressants and psychotropic drugs have the characteristics of negative effects and high rate of relapse. Therefore, researchers continue to seek suitable interventions. cAMP response element binding protein (CREB) belongs to a protein family and is widely distributed in the majority of brain cells that function as a transcription factor. It has been demonstrated that CREB plays an important role in neurogenesis, synaptic plasticity, and neuronal growth. This review provides a 10-year update of the 2013 systematic review on the multidimensional roles of CREB-mediated transcriptional signaling in psychiatric disorders. We also summarize the classification of psychiatric disorders and elucidate the involvement of CREB and related downstream signalling pathways in psychiatric disorders. Importantly, we analyse the CREB-related signal pathways involving antidepressants and antipsychotics to relieve the pathological process of psychiatric disorders. This review emphasizes that CREB signalling may have a vast potential to treat psychiatric disorders like depression. Furthermore, it would be helpful for the development of potential medicine to make up for the imperfection of current antidepressants and antipsychotics.

Cite this article as:

Guan Wei, Ni Mei-Xin, Gu Hai-Juan and Yang Yang*, CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders, Current Neuropharmacology 2024; 22 () . https://dx.doi.org/10.2174/1570159X22666240206111838